|
セキグチ ハルキ
SEKIGUCHI Haruki
関口 治樹 所属 医学部 医学科(東京女子医科大学病院) 職種 准教授 |
|
| 論文種別 | 原著 |
| 言語種別 | 英語 |
| 査読の有無 | 査読あり |
| 表題 | Baseline serum sitosterol level as predictor of adverse clinical events in acute coronary syndrome patients with dyslipidaemia: A sub-analysis of HIJ-PROPER. |
| 掲載誌名 | 正式名:Atherosclerosis 略 称:Atherosclerosis ISSNコード:0021-9150/1879-1484 |
| 掲載区分 | 国外 |
| 出版社 | Elsevier B.V. |
| 巻・号・頁 | 274,pp.139-145 |
| 著者・共著者 | YAMAGUCHI Junichi†*, KAWADA-WATANABE Erisa, KOYANAGI Ryo, ARASHI Hiroyuki, SEKIGUCHI Haruki, NAKAO Koichi, TOBARU Tetsuya, TANAKA Hiroyuki, OKA Toshiaki, ENDO Yasuhiro, SAITO Katsumi, UCHIDA Tatsuro, MATSUI Kunihiko, OGAWA Hiroshi, HAGIWARA Nobuhisa |
| 発行年月 | 2018/07 |
| 概要 | CONCLUSIONS:
Aggressive lipid-lowering treatment with ezetimibe had a positive effect on clinical outcomes in the high sitosterol subset of ACS patients with dyslipidaemia, but not in the low sitosterol subset. This effect was independent of LDL-C reduction and suggests that sitosterol measurement on admission in ACS patients might contribute to a "personalised" lipid-lowering approach. |
| DOI | 10.1016/j.atherosclerosis.2018.04.036 |
| PMID | 29772482 |